Effects of a Pragmatic Lifestyle Intervention for Reducing Body Mass in Obese Adults with Obstructive Sleep Apnoea: A Randomised Controlled Trial
Table 1
Baseline group characteristics.
Variable
Control
Intervention
Anthropometry
Body mass (kg)
30
118.3 ± 21.9
30
117.4 ± 24.3
Body mass index (kg·m−2)
30
39.8 ± 7.0
30
38.9 ± 6.9
Body fat (%)
30
40 ± 9
30
39 ± 8
Neck circumference (cm)
30
45 ± 5
30
44 ± 4
Waist circumference (cm)
30
128 ± 14
30
125 ± 16
Hip circumference (cm)
30
129 ± 14
30
125 ± 15
Cardiometabolic
Resting heart rate (bpm)
30
65 ± 14
30
67 ± 11
Resting systolic BP (mmHg)
30
127 ± 11
30
132 ± 15
Resting diastolic BP (mmHg)
30
72 ± 8
30
75 ± 9
Serum cholesterol (mmol·L−1)
21
4.8 3.4, 6.2
22
4.7 3, 6.5
Serum HDL (mmol·L−1)
21
1.2 ± 0.2
22
1.3 ± 0.3
Cholesterol to HDL ratio
21
4.0 ± 0.7
22
4.1 ± 0.7
Serum triglycerides (mmol·L−1)
21
1.7 0.6, 2.8
22
1.8 1.2, 2.4
Serum LDL (mmol·L−1)
21
2.7 ± 0.7
22
2.9 ± 1.1
Serum CRP (mg·L−1)
21
2.9 0.3, 5.5
22
2 −0.1, 4.0
Serum glucose (mmol·L−1)
21
5.7 ± 1.6
22
5.0 ± 1.1
Serum insulin (mU·L−1)
20
29 7, 51
20
27 4, 50
ISWT
ISWD (m)
27
475 ± 240
26
639 ± 198
Post-ex RPE
27
15 ± 2
26
15 ± 2
Post-ex heart rate (bpm)
27
131 ± 28
26
148 ± 21
Post-ex systolic BP (mmHg)
27
169 ± 29
25
192 ± 31
Post-ex diastolic BP (mmHg)
27
86 ± 15
25
93 ± 11
Quality of life
EuroQol EQ5D-3L VAS
30
58 ± 18
30
64 ± 17
Data are presented as mean ± SD or median IQR. BP: blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; CRP: C-reactive protein; ISWT: incremental shuttle walk test; ISWD: incremental shuttle walk distance; RPE: Borg rating of perceived exertion; VAS: Visual Analogue Scale.
